About Bio-Quant
Bio-Quant is a company based in San Diego (United States) founded in 1999 was acquired by Nexmed in November 2009. Bio-Quant operates in a competitive market with competitors including Heidelberg Pharma, Gubra, Tigermed, BioQual and Gentronix, among others.
- Headquarter San Diego, United States
- SectorsHealthcare
- Website bio-quant.com
- Social LinkedIn
- Acquired by Nexmed (Nov 2009)
Investors in Bio-Quant
Bio-Quant has secured backing from 1 investor. Prominent investors backing the company include Nexmed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | nexmed.com | - |
Investor details for Bio-Quant
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Bio-Quant
1 people are tracked at Bio-Quant (1 in leadership).
| Name | Role | Group |
|---|---|---|
Edward Cox | CEO & President | Leadership |
Complete people profiles for Bio-Quant
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Bio-Quant
2 dated milestones of Bio-Quant across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Bio-Quant is founded.
- Exit Acquired by Nexmed.
Competitors of Bio-Quant
Bio-Quant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Heidelberg Pharma, Gubra, Tigermed, BioQual and Gentronix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| heidelberg-pharma.com | 1999 | Frankfurt Am Main, Germany | $20M | – | Provider of preclinical services specializing in ADCs (Antibody Drug Conjugates) | |
| gubra.dk | 2008 | Horsholm, Denmark | – | – | Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided. | |
| tigermedgrp.com | 2004 | Hangzhou, China | – | 15 | Drug development and preclinical services are provided by Tigermed. | |
| bioqual.com | 1981 | Rockville, United States | – | 193 | Contract research on infectious disease models is conducted. | |
| gentronix.co.uk | 1999 | Alderley Edge, United Kingdom | $3.84M | 1 | In-vitro and in-vivo genetic toxicology screening services are provided. | |
| simrbio.com | 2014 | Shanghai, China | $20.76M | – | Diversified preclinical services for brain-related disorders are provided. | |
| aquila-bm.com | 2011 | Edinburgh, United Kingdom | – | 489 | Preclinical services in immunology, regeneration, neuroscience, and histology are provided. | |
| gvrp.in | 2020 | Hyderabad, India | – | 8 | A platform for research and drug development services is offered. | |
| phaxiam.com | 2004 | Lyon, France | $15.8M | – | Antibacterial treatments using bacteriophages are developed for resistant infections. |
Detailed competitors of Bio-Quant
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bio-Quant
Websites that share an audience with Bio-Quant (bio-quant.com).
Websites whose visitors overlap most with Bio-Quant. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| edqm.eu | 100% | – | #199,638 | View details | |
| advancedsynthesis.com | 100% | – | – | View details | |
| vircell.com | 66% | – | #787,345 | View details |
Similar companies to Bio-Quant
10 companies that operate in the same segment as Bio-Quant (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bio-Quant
Bio-Quant was founded in 1999.
Bio-Quant is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Edward Cox is the current CEO of Bio-Quant.
Bio-Quant was founded in 1999 in San Diego, United States, as a provider of biomedical services within the pharmaceutical sector. Support is offered for pre-IND enabling studies, including pharmacology, pharmacokinetics, and toxicology assessments. Focus is placed on immunology and inflammation, oncology, and metabolic diseases, with in vitro protein binding studies also conducted. Acquisition by NexMed has been completed.
Bio-Quant's top competitors include Heidelberg Pharma, PHAXIAM and Gubra.
Bio-Quant has 1 investor. Key investors include Nexmed.
Yes. Bio-Quant was acquired by Nexmed in November 2009.